SCHEMBL23533463

SCHEMBL23533463

C(=CCCC1OCCO1)CCOCc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.40
PDE4D Q08499 1/20 0.39
TAAR1 Q96RJ0 1/20 0.37
GBA1 P04062 2/20 0.36
UGCG Q16739 2/20 0.36
GBA2 Q9HCG7 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
LTA4H P09960 1/20 0.35
TEAD3 Q99594 1/20 0.35
IDO1 P14902 1/20 0.34
NAAA Q02083 1/20 0.34
HTT P42858 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
LMNA P02545 1/20 0.34
EPHX2 P34913 1/20 0.34
AGTR2 P50052 1/20 0.34
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA7 P43166 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23533462 1.00 TSHR (0.40) TSHRPDE4DTAAR1GBA1UGCG
SCHEMBL8935841 0.84 TSHR (0.48) TSHRPDE4DTAAR1GBA1UGCG
SCHEMBL26604377 0.79 MEN1 (0.51) TSHRPDE4DTAAR1GBA1UGCG
SCHEMBL713523 0.77 TSHR (0.52) TSHRPDE4DTAAR1HTTLMNA
SCHEMBL27661883 0.74 TSHR (0.52) TSHRLTA4HTEAD3IDO1NAAA
SCHEMBL7794029 0.74 TSHR (0.52) TSHRTAAR1LTA4HIDO1NAAA
SCHEMBL4055858 0.73 TSHR (0.56) TSHRTAAR1LTA4HIDO1NAAA
SCHEMBL23533455 0.73 PDE4D (0.39) TSHRPDE4DTAAR1GBA1UGCG
SCHEMBL23533370 0.73 PDE4D (0.39) TSHRPDE4DTAAR1GBA1UGCG
SCHEMBL7197655 0.73 TSHR (0.56) TSHRTAAR1MEN1KMT2AIDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230107538-A1 CYCLOALKYL-CONTAINING CARBOXYLIC ACIDS AND USES THEREOF Liminal Biosciences Limited (GB) 2023-04-06 US disclosed
EP-4076649-A1 CYCLOALKYL-CONTAINING CARBOXYLIC ACIDS AND USES THEREOF Liminal Biosciences Limited (GB) 2022-10-26 EP disclosed
CN-114828958-A Cycloalkyl-containing carboxylic acids and use thereof 里米诺生物科学有限公司 2022-07-29 CN disclosed
WO-2021124272-A1 CYCLOALKYL-CONTAINING CARBOXYLIC ACIDS AND USES THEREOF Liminal Biosciences Limited (GB) 2021-06-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230107538-A1 CYCLOALKYL-CONTAINING CARBOXYLIC ACIDS AND USES THEREOF HCCS, CCL11, BCAT1 TSHR 3796/4885PDE4D 4463/4885TAAR1 1315/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.